Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 6:08 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 109 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Reusable Clear all

Conditions: Rheumatoid Arthritis, Psoriatic Arthritis
Interventions: Etanercept / Autoinjector A; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years and older
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 13
States / cities: Huntsville, Alabama • Peoria, Arizona • Phoenix, Arizona + 10 more

Conditions: Diabetes Mellitus
Interventions: Connected insulin pen and smartphone app, Inactive connected insulin pen without smartphone app; Device
Lead sponsor: Companion Medical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Newport Beach, California

Conditions: Hemoglobin Results
Interventions: Masimo Pronto Rad 7 Non-Invasive hemoglobin monitor, Standard Laboratory Blood Draw and Hemoglobin Analysis; Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 30 Days to 18 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Stress Urinary Incontinence
Interventions: Vaginal pessary; Device
Lead sponsor: Liv Labs Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 3
States / cities: Chicago, Illinois • Lake Forest, Illinois • Columbus, Ohio

Conditions: Meibomian Gland Dysfunction (Disorder)
Interventions: TearCare®; Device
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 29 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Visual Acuity
Interventions: senofilcon A Multifocal, senofilcon A Sphere, etafilcon A Multifocal, etafilcon A Sphere; Device
Lead sponsor: Johnson & Johnson Vision Care, Inc.; Industry
Eligibility: 40 Years to 70 Years
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 6
States / cities: Whittier, California • Jacksonville, Florida • Maitland, Florida + 3 more

Conditions: Cancer
Interventions: 1,25 (OH)2 D3, Inspiratory isometric resistance training, Oral Placebo, Sham Inspiratory Isometric Resistance Training, Threshold Inspiratory Muscle Trainer (IMT); Drug · Other · Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Refractive Ametropia
Interventions: Serafilcon A contact lenses, Senofilcon A contact lenses, CLEAR CARE; Device
Lead sponsor: Alcon Research; Industry
Eligibility: 18 Years and older
Enrollment: 190 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 15
States / cities: Los Angeles, California • Oakland, California • San Francisco, California + 11 more

Conditions: Head and Neck Cancer (H&N), Oral Mucositis (Ulcerative) Due to Radiation, Stomatitis (Oral Mucositis), Xerostomia Due to Radiotherapy, Radiation Toxicity
Interventions: ORAL CARE PRODUCT KIT; Other
Lead sponsor: UNCANCER LLC; Industry
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Clearwater, Florida

Conditions: Glomerular Filtration Rate, Heart Failure
Interventions: Lumitrace, MediBeacon Transdermal Glomerular Filtration Rate Measurement System (tGFR), Iohexol; Device · Drug
Lead sponsor: MediBeacon; Industry
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Adenoma, Colorectal Cancer
Interventions: ENDOCUFF VISION® device, G-EYE® colonoscope; Device
Lead sponsor: Dr. Horst Schmidt Klinik GmbH; Industry
Eligibility: Not listed
Enrollment: 970 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 2
States / cities: Indianapolis, Indiana • New York, New York

Conditions: Hearing Loss, Aging
Interventions: Clinic-based audiological rehabilitative service delivery, Telehealth audiological rehabilitative service delivery; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 73 Years to 88 Years
Enrollment: 339 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 4
States / cities: Hagerstown, Maryland • Minneapolis, Minnesota • Jackson, Mississippi + 1 more

Conditions: Healthy
Interventions: Hemoglobin Sensor ((Rainbow Reusable DCI, DCIP)); Device
Lead sponsor: Masimo Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 354 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Irvine, California

Conditions: Diabetes Mellitus, Non-Insulin-Dependent
Interventions: insulin glargine (HOE901), omega-3 polyunsaturated fatty acids (PUFA), placebo, reusable pen device for insulin injection; Drug · Device
Lead sponsor: Sanofi; Industry
Eligibility: 50 Years and older
Enrollment: 12,537 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2011
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Pregnancy Anemia
Interventions: Masimo RAD 67; Device
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Segmental Dysfunction of the Lumbar Spine, Back Pain, Leg Pain
Interventions: Chiropractic, Exercise, Cryotherapy, Spinalator; Other · Device
Lead sponsor: Leach Chiropractic Clinic; Other
Eligibility: 18 Years to 75 Years
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Starkville, Mississippi

Conditions: Myopia
Interventions: Control Lenses (comfilcon A with current process), Test Lenses (comfilcon A with novel process); Device
Lead sponsor: CooperVision International Limited (CVIL); Industry
Eligibility: 18 Years and older
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 5
States / cities: Berkeley, California • Bloomington, Indiana • New York, New York + 2 more

Conditions: Visual Acuity
Interventions: JJVC Marketed Contact Lens; Device
Lead sponsor: Johnson & Johnson Vision Care, Inc.; Industry
Eligibility: 18 Years to 39 Years · Female only
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Critically Ill Patients, Cardiovascular Surgery Telemetry Patients
Interventions: Disposable ECG-LW; Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: Not listed
Enrollment: 4,056 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Carpal Tunnel Syndrome, Perioperative/Postoperative Complications
Interventions: Polarcare Machine, Standard of care ice therapy; Other
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Myopia
Interventions: comfilcon A, samfilcon A; Device
Lead sponsor: CooperVision, Inc.; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 2
States / cities: Whittier, California • Medina, Minnesota

Conditions: Refractive Errors
Interventions: Serafilcon A contact lenses, Senofilcon A contact lenses, CLEAR CARE; Device
Lead sponsor: Alcon Research; Industry
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 5
States / cities: Maitland, Florida • Medina, Minnesota • Granville, Ohio + 2 more

Conditions: Urinary Incontinence, Cystic Fibrosis
Interventions: Reusable Underwear, Disposable urethral support, Pelvic floor physical therapy; Device · Behavioral
Lead sponsor: Megan Bradley; Other
Eligibility: 18 Years to 99 Years · Female only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Diabetes Mellitus, Type 2
Interventions: Water Up! at Home; Behavioral
Lead sponsor: George Washington University; Other
Eligibility: 18 Years and older
Enrollment: 92 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Search by objective public record fields.

Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject Etanercept

Connected Pens for Diabetes Study

Comparing Validity of Non-Invasive Hemoglobin Monitoring to Laboratory Results in Critically Ill Children

Pippa Pessary Study (Clinical Trial)

TearCare in Young Adults

Clinical Evaluation of a Reusable Multifocal Optical Design in a Presbyopic Population Phase 2

Maintain Respiratory Muscle Function and Reduce Pneumonia Risk in Cancer Patients

The Clinical Performance of Two Reusable Silicone Hydrogel Contact Lenses

Oral Care Program for Mouth Side Effects During Head and Neck Radiation Therapy

MediBeacon® Transdermal GFR System for the Evaluation of Kidney Function in Adults With Heart Failure

Comparison of Adenoma Detection Rate With ENDOCUFF VISION® vs. G-EYE®

ACHIEVE Hearing Intervention Follow-Up Study

Accuracy of Noninvasive Hemoglobin Sensor (Rainbow Reusable DCI)

The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)

Non-invasive Point-Of-Care Hemoglobin Testing In An Obstetric Population

Clinical Correlates of Pressure Pain Thresholds in Back and Leg Pain

Clinical Evaluation of Reusable Soft Contact Lenses

Clinical Evaluation of 2-Week Reusable ACUVUE 2 Vivid Style

ECG Leadwires: Disposable Versus Cleaned, Reusable

Effect of Cooling Therapy for Post-Operative Pain in Open Carpal Tunnel Release

Multi-Center Clinical Evaluation of Two Reusable Soft Contact Lenses

Clinical Performance of Two Reusable Silicone Hydrogel Contact Lenses

Cystic Fibrosis and Urinary Incontinence

Water Up@ At Home: An Intervention to Replace Sugary Drinks With Water